Category:fragrance agents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Boiling Point: | 347.00 to 348.00 °C. @ 760.00 mm Hg (est)
|
Flash Point: | 295.00 °F. TCC ( 146.30 °C. ) (est)
|
logP (o/w): | 4.527 (est) |
Soluble in: |
| alcohol | | water, 0.2202 mg/L @ 25 °C (est) |
Insoluble in: |
| water |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
Not determined
|
Dermal Toxicity: |
Not determined
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Safety References:
References:
| 1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethanone |
NIST Chemistry WebBook: | Search Inchi |
Pubchem (cid): | 87186 |
Pubchem (sid): | 135043484 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| ethanone, 1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)- | 1-(3,5,5,8,8- | pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one | 1-(3,5,5,8,8- | pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone | 1-(3,5,5,8,8- | pentamethyl-6,7-dihydronaphthalen-2-yl)ethanone | 1-(5,6,7,8- | tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)ethan-1-one | 1-(5,6,7,8- | tetrahydro-3',5',5',8',8'-pentamethyl-2-naphthalenyl)-ethanone | 5',6',7',8'- | tetrahydro-3',5',5',8',8'-pentamethyl-2'-acetonaphthone |
Articles:
PubMed:A review of the medicinal potentials of plants of the genus Vernonia (Asteraceae). |
PubMed:Modulation of cytotoxic T lymphocyte, natural killer cell, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by Vernonia cinerea L. and vernolide-A in BALB/c mice via enhanced production of cytokines IL-2 and IFN-γ. |
PubMed:Vernolide-A inhibits radiation-induced hypoxia-mediated tumor angiogenesis by regulating HIF-1α, MMP-2, MMP-9, and VEGF. |
PubMed:Antimetastatic potential of vernolide-A, a sesquiterpenoid from Vernonia cinerea L. |
PubMed:Vernolide-A, a sesquiterpene lactone from Vernonia cinerea, induces apoptosis in B16F-10 melanoma cells by modulating p53 and caspase-3 gene expressions and regulating NF-κB-mediated bcl-2 activation. |
PubMed:Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP. |
PubMed:Effect of vernolide-A, a sesquiterpene lactone from Vernonia cinerea L., on cell-mediated immune response in B16F-10 metastatic melanoma-bearing mice. |
PubMed:Antimalarial activity of sesquiterpene lactones from Vernonia cinerea. |
PubMed:Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. |
PubMed:Sesquiterpene lactones with potent cytotoxic activities from Vernonia chinensis. |
PubMed:Two novel sesquiterpene lactones, cytotoxic vernolide-A and -B, from Vernonia cinerea. |
PubMed:Isolation and identification of antibacterial compounds from Vernonia colorata leaves. |
PubMed:Use of Vernonia amygdalina by wild chimpanzee: possible roles of its bitter and related constituents. |
|